• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA¿ CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383512
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Hemolysis (1886)
Event Date 08/01/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that blood unable to/or drew very slow which lead to hemolyzed specimen with a bd nexiva¿ closed iv catheter system.The following information was provided by the initial reporter: (2 of 5) catheter was in the vein and would not draw blood/ or drew very slow to hemolyze specimen.Blue needless transfer device nor syringe did not work to draw blood/ or drew very slow to lead to hemolysis and patient being stuck additional times for blood.Iv catheter flushed without problems.Catheter was discarded after being removed from patient, but additional product information provided below.This event required patient to be stuck an additional time for iv placement and blood draw.
 
Manufacturer Narrative
Investigation summary: there were no samples or photos available to bd for evaluation.Therefore, bd was unable to perform a thorough investigation to verify the reported issue.Since, an investigation could not be performed bd was unable to determine a possible root cause.The manufacturing facility has been notified of this event but without a sample no corrective actions could be identified.A review of the device history record was performed and no quality issues were found during production.
 
Event Description
It was reported that blood unable to/or drew very slow which lead to hemolyzed specimen with a bd nexiva¿ closed iv catheter system.The following information was provided by the initial reporter: (2 of 5) catheter was in the vein and would not draw blood/ or drew very slow to hemolyze specimen.Blue needless transfer device nor syringe did not work to draw blood/ or drew very slow to lead to hemolysis and patient being stuck additional times for blood.Iv catheter flushed without problems.Catheter was discarded after being removed from patient, but additional product information provided below.This event required patient to be stuck an additional time for iv placement and blood draw.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA¿ CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key8937488
MDR Text Key157461000
Report Number1710034-2019-00933
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835127
UDI-Public30382903835127
Combination Product (y/n)N
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2022
Device Catalogue Number383512
Device Lot Number9137627
Initial Date Manufacturer Received 08/09/2019
Initial Date FDA Received08/27/2019
Supplement Dates Manufacturer Received08/09/2019
Supplement Dates FDA Received09/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-